Results 181 to 190 of about 68,419 (263)

Yellow Fever Vaccine-Associated Viscerotropic Disease: A Unique Case of Atraumatic Splenic Rupture. [PDF]

Case Rep Infect Dis
Nortey E, Bediako EM, Mould GK, Mills-Annoh A, Ekremet K, Kyei-Baffour P, Ekem A, Clarke JCA, Apaloo EFEK, Quartey-Papafio S.   +9 more
europepmc   +1 more source

Public health role for fractional dosage of yellow fever vaccine. [PDF]

Lancet, 2021
Staples JE, Alvarez AR.
europepmc   +1 more source

Recombinant Yellow Fever Viruses Are Effective Therapeutic Vaccines for Treatment of Murine Experimental Solid Tumors and Pulmonary Metastases [PDF]

, 2000
Andrés McAllister, Alejandra E. Arbetman, Stefanie Mandl, Claudia Peña-Rossi, Raul Andino   +4 more
openalex   +1 more source

Low-Dose Yellow Fever Vaccine in Adults in Africa. [PDF]

N Engl J Med
Kimathi D, Juan-Giner A, Bob NS, Orindi B, Namulwana ML, Diatta A, Cheruiyot S, Fall G, Dia M, Hamaluba MM, Nyehangane D, Karanja HK, Gitonga JN, Mugo D, Omuoyo DO, Hussein M, Oloo E, Kamau N, Wafula J, Bendera J, Silvester N, Mwavita J, Joshua M, Mwendwa J, Agababyona C, Ngetsa C, Aisha N, Moki F, Buluku T, Munene M, Mwanga-Amumpaire J, Lutwama J, Kayiwa J, Kamaara E, Barrett AD, Kaleebu P, Bejon P, Sall AA, Grais RF, Warimwe GM, NIFTY Investigators.   +40 more
europepmc   +1 more source

A spray freeze dried micropellet based formulation proof-of-concept for a yellow fever vaccine candidate

, 2019
Didier Clénet, Véronique Hourquet, Bertrand Woinet, H. Ponceblanc, Manuel Vangelisti   +4 more
openalex   +1 more source

Safety and Immunogenicity of the Attenuated Yellow Fever Vaccine in Several Neotropical Primate Species. [PDF]

Vaccines (Basel)
Paula NF, Vieira AD, Santos DOD, Souza LDR, Coelho CM, Tinoco HP, Lima PCS, Motta ROC, Pereira VDS, Carvalho MPN, Fernandes CB, Azevedo AS, Arruda MS, Costa TA, Drumond BP, Leme FOP, Freire MDS, Paixão TAD, Oliveira AR, Santos RL.   +19 more
europepmc   +1 more source

Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial. [PDF]

PLoS Negl Trop Dis, 2023
Sandberg JT, Löfling M, Varnaitė R, Emgård J, Al-Tawil N, Lindquist L, Gredmark-Russ S, Klingström J, Loré K, Blom K, Ljunggren HG.   +10 more
europepmc   +1 more source

Description of a Prospective 17DD Yellow Fever Vaccine Cohort in Recife, Brazil [PDF]

, 2011
Andréa Barbosa de Melo, Maria da Paz C. da Silva, Maria Cecília F. Magalhães, Laura H. V. G. Gil, Eduardo Maia Freese de Carvalho, Ulisses Braga-Neto, Giovani Rota Bertani, Ernesto T. A. Marques, Marli Tenório Cordeiro   +8 more
openalex   +1 more source

Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease. [PDF]

J Bras Nefrol
Distenhreft JIQ, Couto-Lima D, Andreazzi CS, Thomazini JFRC, Vasconcellos Filho LM, Falqueto A, Luchi WM.   +6 more
europepmc   +1 more source

Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals. [PDF]

An Bras Dermatol, 2021
Almeida LR, Criado RF, Criado PR, Ensina LF, Abdalla BMZ, Quaresma JAS.   +5 more
europepmc   +1 more source